Global, regional, and national burdens of hip osteoarthritis from 1990 to 2019: estimates from the 2019 Global Burden of Disease Study

Hip osteoarthritis is a common disabling condition of the hip joint and is associated with a substantial health burden. We assessed the epidemiological patterns of hip osteoarthritis from 1990 to 2019 by sex, age, and socio-demographic index (SDI). Age-standardized rates (ASRs) were obtained for the...

Full description

Saved in:
Bibliographic Details
Published inArthritis research & therapy Vol. 24; no. 1; pp. 8 - 11
Main Authors Fu, Ming, Zhou, Hongming, Li, Yushi, Jin, Hai, Liu, Xiqing
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 03.01.2022
BioMed Central
BMC
Subjects
Age
Age-standardized rates
Arthritis
Care and treatment
Collaboration
Diagnosis
Disability evaluation
Disability-adjusted life years
Disease
Females
Global Burden of Disease
Global Health
High income
Hip osteoarthritis
Humans
Incidence
Methods
Middle Aged
Osteoarthritis
Osteoarthritis, Hip - diagnosis
Osteoarthritis, Hip - epidemiology
Pain
Population
Quality-Adjusted Life Years
Risk factors
Sexes
Trends
China
United Kingdom > UK
United States > US
Timor-Leste
East Asia
Tokelau Islands
North America
Iceland
Sub-Saharan Africa
Niue
Oceania
India
South Korea
Denmark
Nauru
Nigeria
Yemen
Hip osteoarthritis
Age-standardized rates
Disability-adjusted life years
Incidence
Online AccessGet full text
ISSN1478-6362
1478-6354
1478-6362
DOI10.1186/s13075-021-02705-6

Cover

Abstract Hip osteoarthritis is a common disabling condition of the hip joint and is associated with a substantial health burden. We assessed the epidemiological patterns of hip osteoarthritis from 1990 to 2019 by sex, age, and socio-demographic index (SDI). Age-standardized rates (ASRs) were obtained for the incidence and disability-adjusted life years (DALYs) of hip osteoarthritis from 1990 to 2019 for 21 regions, encompassing a total of 204 countries and territories. The estimated annual percentage changes (EAPCs) of ASRs were calculated to evaluate the trends in the incidence and DALYs of hip osteoarthritis over these 30 years. Globally, from 1990 to 2019, the age-standardized incidence rate (ASIR) of hip osteoarthritis increased from 17.02 per 100,000 persons to 18.70 per 100,000 persons, with an upward trend in the EAPC of 0.32 (0.29-0.34), whereas the age-standardized DALY rate increased from 11.54 per 100,000 persons to 12.57 per 100,000 persons, with an EAPC of 0.29 (0.27-0.32). In 2019, the EAPCs of the ASIR and age-standardized DALY rate of hip osteoarthritis were positively associated with the SDI of hip osteoarthritis. In 1990 and 2019, the incidence of hip osteoarthritis was unimodally distributed across different age groups, with a peak incidence in the 60-64-year-old age group, whereas the DALYs increased with age. The incidence and DALYs of hip osteoarthritis have been increasing globally. The EAPCs of the ASIR and age-standardized DALY rate were particularly significant in developed regions and varied across nations and regions, indicating the urgent need for governments and medical institutions to increase the awareness regarding risk factors, consequences of hip osteoarthritis.
AbstractList Hip osteoarthritis is a common disabling condition of the hip joint and is associated with a substantial health burden. We assessed the epidemiological patterns of hip osteoarthritis from 1990 to 2019 by sex, age, and socio-demographic index (SDI).BACKGROUNDHip osteoarthritis is a common disabling condition of the hip joint and is associated with a substantial health burden. We assessed the epidemiological patterns of hip osteoarthritis from 1990 to 2019 by sex, age, and socio-demographic index (SDI).Age-standardized rates (ASRs) were obtained for the incidence and disability-adjusted life years (DALYs) of hip osteoarthritis from 1990 to 2019 for 21 regions, encompassing a total of 204 countries and territories. The estimated annual percentage changes (EAPCs) of ASRs were calculated to evaluate the trends in the incidence and DALYs of hip osteoarthritis over these 30 years.METHODSAge-standardized rates (ASRs) were obtained for the incidence and disability-adjusted life years (DALYs) of hip osteoarthritis from 1990 to 2019 for 21 regions, encompassing a total of 204 countries and territories. The estimated annual percentage changes (EAPCs) of ASRs were calculated to evaluate the trends in the incidence and DALYs of hip osteoarthritis over these 30 years.Globally, from 1990 to 2019, the age-standardized incidence rate (ASIR) of hip osteoarthritis increased from 17.02 per 100,000 persons to 18.70 per 100,000 persons, with an upward trend in the EAPC of 0.32 (0.29-0.34), whereas the age-standardized DALY rate increased from 11.54 per 100,000 persons to 12.57 per 100,000 persons, with an EAPC of 0.29 (0.27-0.32). In 2019, the EAPCs of the ASIR and age-standardized DALY rate of hip osteoarthritis were positively associated with the SDI of hip osteoarthritis. In 1990 and 2019, the incidence of hip osteoarthritis was unimodally distributed across different age groups, with a peak incidence in the 60-64-year-old age group, whereas the DALYs increased with age.RESULTSGlobally, from 1990 to 2019, the age-standardized incidence rate (ASIR) of hip osteoarthritis increased from 17.02 per 100,000 persons to 18.70 per 100,000 persons, with an upward trend in the EAPC of 0.32 (0.29-0.34), whereas the age-standardized DALY rate increased from 11.54 per 100,000 persons to 12.57 per 100,000 persons, with an EAPC of 0.29 (0.27-0.32). In 2019, the EAPCs of the ASIR and age-standardized DALY rate of hip osteoarthritis were positively associated with the SDI of hip osteoarthritis. In 1990 and 2019, the incidence of hip osteoarthritis was unimodally distributed across different age groups, with a peak incidence in the 60-64-year-old age group, whereas the DALYs increased with age.The incidence and DALYs of hip osteoarthritis have been increasing globally. The EAPCs of the ASIR and age-standardized DALY rate were particularly significant in developed regions and varied across nations and regions, indicating the urgent need for governments and medical institutions to increase the awareness regarding risk factors, consequences of hip osteoarthritis.CONCLUSIONSThe incidence and DALYs of hip osteoarthritis have been increasing globally. The EAPCs of the ASIR and age-standardized DALY rate were particularly significant in developed regions and varied across nations and regions, indicating the urgent need for governments and medical institutions to increase the awareness regarding risk factors, consequences of hip osteoarthritis.
Hip osteoarthritis is a common disabling condition of the hip joint and is associated with a substantial health burden. We assessed the epidemiological patterns of hip osteoarthritis from 1990 to 2019 by sex, age, and socio-demographic index (SDI). Age-standardized rates (ASRs) were obtained for the incidence and disability-adjusted life years (DALYs) of hip osteoarthritis from 1990 to 2019 for 21 regions, encompassing a total of 204 countries and territories. The estimated annual percentage changes (EAPCs) of ASRs were calculated to evaluate the trends in the incidence and DALYs of hip osteoarthritis over these 30 years. Globally, from 1990 to 2019, the age-standardized incidence rate (ASIR) of hip osteoarthritis increased from 17.02 per 100,000 persons to 18.70 per 100,000 persons, with an upward trend in the EAPC of 0.32 (0.29-0.34), whereas the age-standardized DALY rate increased from 11.54 per 100,000 persons to 12.57 per 100,000 persons, with an EAPC of 0.29 (0.27-0.32). In 2019, the EAPCs of the ASIR and age-standardized DALY rate of hip osteoarthritis were positively associated with the SDI of hip osteoarthritis. In 1990 and 2019, the incidence of hip osteoarthritis was unimodally distributed across different age groups, with a peak incidence in the 60-64-year-old age group, whereas the DALYs increased with age. The incidence and DALYs of hip osteoarthritis have been increasing globally. The EAPCs of the ASIR and age-standardized DALY rate were particularly significant in developed regions and varied across nations and regions, indicating the urgent need for governments and medical institutions to increase the awareness regarding risk factors, consequences of hip osteoarthritis.
Hip osteoarthritis is a common disabling condition of the hip joint and is associated with a substantial health burden. We assessed the epidemiological patterns of hip osteoarthritis from 1990 to 2019 by sex, age, and socio-demographic index (SDI). Age-standardized rates (ASRs) were obtained for the incidence and disability-adjusted life years (DALYs) of hip osteoarthritis from 1990 to 2019 for 21 regions, encompassing a total of 204 countries and territories. The estimated annual percentage changes (EAPCs) of ASRs were calculated to evaluate the trends in the incidence and DALYs of hip osteoarthritis over these 30 years. Globally, from 1990 to 2019, the age-standardized incidence rate (ASIR) of hip osteoarthritis increased from 17.02 per 100,000 persons to 18.70 per 100,000 persons, with an upward trend in the EAPC of 0.32 (0.29-0.34), whereas the age-standardized DALY rate increased from 11.54 per 100,000 persons to 12.57 per 100,000 persons, with an EAPC of 0.29 (0.27-0.32). In 2019, the EAPCs of the ASIR and age-standardized DALY rate of hip osteoarthritis were positively associated with the SDI of hip osteoarthritis. In 1990 and 2019, the incidence of hip osteoarthritis was unimodally distributed across different age groups, with a peak incidence in the 60-64-year-old age group, whereas the DALYs increased with age. The incidence and DALYs of hip osteoarthritis have been increasing globally. The EAPCs of the ASIR and age-standardized DALY rate were particularly significant in developed regions and varied across nations and regions, indicating the urgent need for governments and medical institutions to increase the awareness regarding risk factors, consequences of hip osteoarthritis.
Background Hip osteoarthritis is a common disabling condition of the hip joint and is associated with a substantial health burden. We assessed the epidemiological patterns of hip osteoarthritis from 1990 to 2019 by sex, age, and socio-demographic index (SDI). Methods Age-standardized rates (ASRs) were obtained for the incidence and disability-adjusted life years (DALYs) of hip osteoarthritis from 1990 to 2019 for 21 regions, encompassing a total of 204 countries and territories. The estimated annual percentage changes (EAPCs) of ASRs were calculated to evaluate the trends in the incidence and DALYs of hip osteoarthritis over these 30 years. Results Globally, from 1990 to 2019, the age-standardized incidence rate (ASIR) of hip osteoarthritis increased from 17.02 per 100,000 persons to 18.70 per 100,000 persons, with an upward trend in the EAPC of 0.32 (0.29-0.34), whereas the age-standardized DALY rate increased from 11.54 per 100,000 persons to 12.57 per 100,000 persons, with an EAPC of 0.29 (0.27-0.32). In 2019, the EAPCs of the ASIR and age-standardized DALY rate of hip osteoarthritis were positively associated with the SDI of hip osteoarthritis. In 1990 and 2019, the incidence of hip osteoarthritis was unimodally distributed across different age groups, with a peak incidence in the 60-64-year-old age group, whereas the DALYs increased with age. Conclusions The incidence and DALYs of hip osteoarthritis have been increasing globally. The EAPCs of the ASIR and age-standardized DALY rate were particularly significant in developed regions and varied across nations and regions, indicating the urgent need for governments and medical institutions to increase the awareness regarding risk factors, consequences of hip osteoarthritis. Keywords: Hip osteoarthritis, Age-standardized rates, Incidence, Disability-adjusted life years
Background Hip osteoarthritis is a common disabling condition of the hip joint and is associated with a substantial health burden. We assessed the epidemiological patterns of hip osteoarthritis from 1990 to 2019 by sex, age, and socio-demographic index (SDI). Methods Age-standardized rates (ASRs) were obtained for the incidence and disability-adjusted life years (DALYs) of hip osteoarthritis from 1990 to 2019 for 21 regions, encompassing a total of 204 countries and territories. The estimated annual percentage changes (EAPCs) of ASRs were calculated to evaluate the trends in the incidence and DALYs of hip osteoarthritis over these 30 years. Results Globally, from 1990 to 2019, the age-standardized incidence rate (ASIR) of hip osteoarthritis increased from 17.02 per 100,000 persons to 18.70 per 100,000 persons, with an upward trend in the EAPC of 0.32 (0.29–0.34), whereas the age-standardized DALY rate increased from 11.54 per 100,000 persons to 12.57 per 100,000 persons, with an EAPC of 0.29 (0.27–0.32). In 2019, the EAPCs of the ASIR and age-standardized DALY rate of hip osteoarthritis were positively associated with the SDI of hip osteoarthritis. In 1990 and 2019, the incidence of hip osteoarthritis was unimodally distributed across different age groups, with a peak incidence in the 60–64-year-old age group, whereas the DALYs increased with age. Conclusions The incidence and DALYs of hip osteoarthritis have been increasing globally. The EAPCs of the ASIR and age-standardized DALY rate were particularly significant in developed regions and varied across nations and regions, indicating the urgent need for governments and medical institutions to increase the awareness regarding risk factors, consequences of hip osteoarthritis.
Abstract Background Hip osteoarthritis is a common disabling condition of the hip joint and is associated with a substantial health burden. We assessed the epidemiological patterns of hip osteoarthritis from 1990 to 2019 by sex, age, and socio-demographic index (SDI). Methods Age-standardized rates (ASRs) were obtained for the incidence and disability-adjusted life years (DALYs) of hip osteoarthritis from 1990 to 2019 for 21 regions, encompassing a total of 204 countries and territories. The estimated annual percentage changes (EAPCs) of ASRs were calculated to evaluate the trends in the incidence and DALYs of hip osteoarthritis over these 30 years. Results Globally, from 1990 to 2019, the age-standardized incidence rate (ASIR) of hip osteoarthritis increased from 17.02 per 100,000 persons to 18.70 per 100,000 persons, with an upward trend in the EAPC of 0.32 (0.29–0.34), whereas the age-standardized DALY rate increased from 11.54 per 100,000 persons to 12.57 per 100,000 persons, with an EAPC of 0.29 (0.27–0.32). In 2019, the EAPCs of the ASIR and age-standardized DALY rate of hip osteoarthritis were positively associated with the SDI of hip osteoarthritis. In 1990 and 2019, the incidence of hip osteoarthritis was unimodally distributed across different age groups, with a peak incidence in the 60–64-year-old age group, whereas the DALYs increased with age. Conclusions The incidence and DALYs of hip osteoarthritis have been increasing globally. The EAPCs of the ASIR and age-standardized DALY rate were particularly significant in developed regions and varied across nations and regions, indicating the urgent need for governments and medical institutions to increase the awareness regarding risk factors, consequences of hip osteoarthritis.
ArticleNumber 8
Audience Academic
Author Fu, Ming
Li, Yushi
Liu, Xiqing
Jin, Hai
Zhou, Hongming
Author_xml – sequence: 1
  givenname: Ming
  surname: Fu
  fullname: Fu, Ming
– sequence: 2
  givenname: Hongming
  surname: Zhou
  fullname: Zhou, Hongming
– sequence: 3
  givenname: Yushi
  surname: Li
  fullname: Li, Yushi
– sequence: 4
  givenname: Hai
  surname: Jin
  fullname: Jin, Hai
– sequence: 5
  givenname: Xiqing
  surname: Liu
  fullname: Liu, Xiqing
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34980239$$D View this record in MEDLINE/PubMed
BookMark eNp9kttu1DAQhiNURA_wAlwgS9xwQYoPiQ9cIJUCpVIlLoBry3Emu15l48V2kPoCPDdOsoVuhVCUxPH8803G858WR4MfoCieE3xOiORvImFY1CWmJN8C1yV_VJyQSsiSM06P7q2Pi9MYNxhTqmj1pDhmlZKYMnVS_LrqfWP61yjAyvlhWpmhRYNJ8xdqxtDCEJHv0NrtkI8JvAlpHVxyEXXBbxFRCqPkEcVEvUUQk9uaBPtgWsMcQEsd9H7mTbgPLoKJgL6msb19WjzuTB_h2f59Vnz_9PHb5efy5svV9eXFTWk5VamkFbeCK46lFRXUtagb2fLasrYzeacmGMuGdK2RspYCcqTrBBVccMpxfrKz4nrhtt5s9C7kXw232hun5w0fVjp352wPGvK5MVZVmFlSAbWN6VrFDakwQFU3NLPeLazd2GyhtTCkYPoD6GFkcGu98j-1FJQyKjPg1R4Q_I8xH5zeumih780AfoyacsJrpWQ91Xr5QLrxY8gDmlQUK5aZ4q9qZXIDbuh8rmsnqL7givE8fEyy6vwfqny1sHU2W6xzef8g4cX9Rv90eOeiLJCLwAYfY4BOW5dmB2Wy6zXBejKsXgyrs2H1bFg9DYQ-SL2j_yfpNwnF6Qo
CitedBy_id crossref_primary_10_1515_biol_2022_0747
crossref_primary_10_1007_s10787_023_01260_7
crossref_primary_10_2147_JPR_S432106
crossref_primary_10_1016_j_recot_2024_04_004
crossref_primary_10_1002_jor_25421
crossref_primary_10_1007_s11701_024_01949_z
crossref_primary_10_2519_josptopen_2024_0463
crossref_primary_10_1186_s12891_023_06662_w
crossref_primary_10_2298_MPNS22S2047Z
crossref_primary_10_1016_j_maturitas_2022_09_005
crossref_primary_10_1016_j_intimp_2024_112201
crossref_primary_10_1186_s12891_024_07442_w
crossref_primary_10_1007_s00402_024_05250_4
crossref_primary_10_3390_anatomia3030014
crossref_primary_10_1080_09638288_2024_2412185
crossref_primary_10_1186_s12913_022_08999_9
crossref_primary_10_1007_s10238_023_01063_8
crossref_primary_10_1016_j_arthro_2024_08_032
crossref_primary_10_1007_s00402_022_04582_3
crossref_primary_10_1097_CORR_0000000000003445
crossref_primary_10_1186_s12889_024_18968_y
crossref_primary_10_1002_acr_25057
crossref_primary_10_1136_bmjopen_2022_065304
crossref_primary_10_2298_MPNS22S2062S
crossref_primary_10_1007_s11427_023_2593_4
crossref_primary_10_1016_j_jisako_2024_100363
crossref_primary_10_3390_jcm13206194
crossref_primary_10_1016_j_pharma_2024_04_006
crossref_primary_10_1111_1756_185X_15279
crossref_primary_10_2147_DMSO_S419830
crossref_primary_10_1007_s00330_024_11030_w
crossref_primary_10_1007_s00402_023_05105_4
crossref_primary_10_46889_JOSR_2024_5208
crossref_primary_10_1038_s41598_023_37780_z
crossref_primary_10_1007_s00402_024_05505_0
crossref_primary_10_1016_j_jsampl_2024_100056
crossref_primary_10_14302_issn_2474_7785_jarh_22_4271
crossref_primary_10_7759_cureus_41095
crossref_primary_10_1016_j_carbpol_2022_119492
crossref_primary_10_1016_j_joca_2024_08_003
crossref_primary_10_1155_2022_2957844
crossref_primary_10_30629_0023_2149_2023_101_4_5_208_215
crossref_primary_10_1111_jgs_18371
crossref_primary_10_3390_jcm14051525
crossref_primary_10_1177_14034948241265427
crossref_primary_10_1016_j_jot_2025_02_006
crossref_primary_10_3390_metabo12070639
crossref_primary_10_1016_j_apmr_2023_10_007
crossref_primary_10_1186_s10194_023_01659_1
crossref_primary_10_1097_NOR_0000000000000999
crossref_primary_10_15406_ipmrj_2022_07_00314
crossref_primary_10_1186_s12891_024_07513_y
crossref_primary_10_3390_healthcare11121733
crossref_primary_10_1016_j_arth_2023_11_005
crossref_primary_10_5312_wjo_v15_i1_39
crossref_primary_10_1007_s00256_022_04270_8
crossref_primary_10_1007_s00264_023_05938_z
crossref_primary_10_2147_OARRR_S485295
crossref_primary_10_1016_j_cpha_2023_07_007
crossref_primary_10_1016_j_jbiomech_2023_111767
crossref_primary_10_1007_s12011_023_03636_w
crossref_primary_10_3390_app13084665
crossref_primary_10_36425_rehab630518
crossref_primary_10_1016_j_arth_2023_05_042
crossref_primary_10_3390_app12168054
crossref_primary_10_1016_j_recot_2024_07_004
crossref_primary_10_3389_fneur_2022_955367
crossref_primary_10_1051_sicotj_2024055
crossref_primary_10_1002_bab_2588
crossref_primary_10_1038_s41366_024_01653_w
crossref_primary_10_26603_001c_93075
crossref_primary_10_1007_s10067_024_06985_6
crossref_primary_10_1186_s43046_024_00241_3
crossref_primary_10_3390_healthcare12030327
crossref_primary_10_1186_s12995_024_00415_8
crossref_primary_10_3390_jcm13082341
crossref_primary_10_1016_j_ocarto_2023_100427
crossref_primary_10_1056_NEJMoa2400141
crossref_primary_10_1007_s00590_023_03639_2
crossref_primary_10_1016_j_arr_2024_102382
crossref_primary_10_7759_cureus_46361
Cites_doi 10.1136/annrheumdis-2019-216515
10.1136/bmj.i3405
10.1016/S0140-6736(20)30925-9
10.1371/journal.pone.0133858
10.1038/nrrheum.2013.114
10.1016/j.berh.2015.04.015
10.2217/ahe.12.43
10.1007/978-981-13-3681-2_6
10.1016/S0140-6736(14)61682-2
10.1016/S0140-6736(20)32230-3
10.18632/aging.102762
10.1016/S0140-6736(14)60802-3
10.1016/S1836-9553(13)70179-6
10.1001/jamanetworkopen.2020.8759
10.1136/annrheumdis-2013-204763
10.1186/s13045-019-0799-1
10.1002/art.41571
10.1016/j.pop.2013.08.003
10.1016/j.joca.2018.01.015
10.1016/S0140-6736(19)30417-9
10.1016/S0140-6736(18)31665-9
10.1097/PR9.0000000000000843
10.1136/ard.16.4.494
10.1016/j.mcna.2019.10.007
ContentType Journal Article
Copyright 2021. The Author(s).
COPYRIGHT 2022 BioMed Central Ltd.
2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2021
Copyright_xml – notice: 2021. The Author(s).
– notice: COPYRIGHT 2022 BioMed Central Ltd.
– notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s13075-021-02705-6
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE


Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1478-6362
EndPage 11
ExternalDocumentID oai_doaj_org_article_e362334403c14e2cbafd96a140ee45b2
PMC8722328
A693692401
34980239
10_1186_s13075_021_02705_6
Genre Journal Article
GeographicLocations China
United Kingdom--UK
United States--US
Timor-Leste
East Asia
Tokelau Islands
North America
Iceland
Sub-Saharan Africa
Niue
Oceania
India
South Korea
Denmark
Nauru
Nigeria
Yemen
GeographicLocations_xml – name: China
– name: Niue
– name: Tokelau Islands
– name: Iceland
– name: South Korea
– name: Nauru
– name: Denmark
– name: Nigeria
– name: Oceania
– name: North America
– name: United States--US
– name: United Kingdom--UK
– name: Sub-Saharan Africa
– name: Yemen
– name: India
– name: East Asia
– name: Timor-Leste
GroupedDBID ---
.GJ
0R~
23N
2WC
4.4
5GY
5VS
6J9
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABUWG
ACGFS
ACJQM
ADBBV
ADUKV
AEGXH
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIAM
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
E3Z
EBD
EBLON
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
HZ~
INH
INR
ITC
KQ8
M1P
O5R
O5S
O9-
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
U2A
UKHRP
WOQ
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c629t-246c769608c74e5575b8d65c3dfac7451008b1fda88587e65cff7276762606763
IEDL.DBID DOA
ISSN 1478-6362
1478-6354
IngestDate Wed Aug 27 01:25:51 EDT 2025
Thu Aug 21 14:02:52 EDT 2025
Fri Jul 11 06:00:34 EDT 2025
Fri Jul 25 06:29:56 EDT 2025
Tue Jun 17 21:05:48 EDT 2025
Tue Jun 10 20:36:39 EDT 2025
Thu Apr 03 06:58:34 EDT 2025
Tue Jul 01 04:00:58 EDT 2025
Thu Apr 24 23:07:05 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Hip osteoarthritis
Age-standardized rates
Disability-adjusted life years
Incidence
Language English
License 2021. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c629t-246c769608c74e5575b8d65c3dfac7451008b1fda88587e65cff7276762606763
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doaj.org/article/e362334403c14e2cbafd96a140ee45b2
PMID 34980239
PQID 2620938727
PQPubID 42876
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_e362334403c14e2cbafd96a140ee45b2
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8722328
proquest_miscellaneous_2616599852
proquest_journals_2620938727
gale_infotracmisc_A693692401
gale_infotracacademiconefile_A693692401
pubmed_primary_34980239
crossref_citationtrail_10_1186_s13075_021_02705_6
crossref_primary_10_1186_s13075_021_02705_6
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-01-03
PublicationDateYYYYMMDD 2022-01-03
PublicationDate_xml – month: 01
  year: 2022
  text: 2022-01-03
  day: 03
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Arthritis research & therapy
PublicationTitleAlternate Arthritis Res Ther
PublicationYear 2022
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References JH Kellgren (2705_CR8) 1957; 16
M Luong (2705_CR20) 2012; 8
D Hunter (2705_CR22) 2020; 396
2705_CR7
2705_CR6
J Evans (2705_CR2) 2019; 393
Y Deng (2705_CR11) 2020; 12
P Sacitharan (2705_CR21) 2019; 91
K Bennell (2705_CR14) 2013; 59
M Cross (2705_CR4) 2014; 73
2705_CR10
A Usenbo (2705_CR12) 2015; 10
2705_CR1
S Safiri (2705_CR5) 2020; 79
EC Harris (2705_CR19) 2015; 29
F Saberi Hosnijeh (2705_CR17) 2018; 26
L Zhou (2705_CR24) 2019; 12
N Aresti (2705_CR3) 2016; 354
R Agricola (2705_CR18) 2013; 9
Y Deng (2705_CR23) 2020; 3
B Abramoff (2705_CR13) 2020; 104
M Fransen (2705_CR15) 2014; 4
A Kongsted (2705_CR16) 2020; 5
2705_CR25
R Taruc-Uy (2705_CR9) 2013; 40
References_xml – volume: 79
  start-page: 819
  issue: 6
  year: 2020
  ident: 2705_CR5
  publication-title: Ann Rheum Dis.
  doi: 10.1136/annrheumdis-2019-216515
– volume: 354
  start-page: i3405
  year: 2016
  ident: 2705_CR3
  publication-title: BMJ.
  doi: 10.1136/bmj.i3405
– ident: 2705_CR7
  doi: 10.1016/S0140-6736(20)30925-9
– volume: 4
  year: 2014
  ident: 2705_CR15
  publication-title: Cochrane Database Syst Rev
– volume: 10
  issue: 8
  year: 2015
  ident: 2705_CR12
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0133858
– volume: 9
  start-page: 630
  year: 2013
  ident: 2705_CR18
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2013.114
– volume: 29
  start-page: 462
  year: 2015
  ident: 2705_CR19
  publication-title: Best Pract Res Clin Rheumatol
  doi: 10.1016/j.berh.2015.04.015
– volume: 8
  start-page: 413
  issue: 4
  year: 2012
  ident: 2705_CR20
  publication-title: Aging Health.
  doi: 10.2217/ahe.12.43
– volume: 91
  start-page: 123
  year: 2019
  ident: 2705_CR21
  publication-title: Sub-Cellular Biochemistry.
  doi: 10.1007/978-981-13-3681-2_6
– ident: 2705_CR10
  doi: 10.1016/S0140-6736(14)61682-2
– volume: 396
  start-page: 1711
  issue: 10264
  year: 2020
  ident: 2705_CR22
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(20)32230-3
– volume: 12
  start-page: 2545
  issue: 3
  year: 2020
  ident: 2705_CR11
  publication-title: Aging.
  doi: 10.18632/aging.102762
– ident: 2705_CR25
  doi: 10.1016/S0140-6736(14)60802-3
– volume: 59
  start-page: 145
  issue: 3
  year: 2013
  ident: 2705_CR14
  publication-title: J Physiother
  doi: 10.1016/S1836-9553(13)70179-6
– volume: 3
  issue: 6
  year: 2020
  ident: 2705_CR23
  publication-title: JAMA Network Open.
  doi: 10.1001/jamanetworkopen.2020.8759
– volume: 73
  start-page: 1323
  issue: 7
  year: 2014
  ident: 2705_CR4
  publication-title: Ann Rheum Dis.
  doi: 10.1136/annrheumdis-2013-204763
– volume: 12
  start-page: 107
  issue: 1
  year: 2019
  ident: 2705_CR24
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-019-0799-1
– ident: 2705_CR6
  doi: 10.1002/art.41571
– volume: 40
  start-page: 821
  issue: 4
  year: 2013
  ident: 2705_CR9
  publication-title: Primary care.
  doi: 10.1016/j.pop.2013.08.003
– volume: 26
  start-page: 540
  issue: 4
  year: 2018
  ident: 2705_CR17
  publication-title: Osteoarthr Cartil.
  doi: 10.1016/j.joca.2018.01.015
– ident: 2705_CR1
  doi: 10.1016/S0140-6736(19)30417-9
– volume: 393
  start-page: 647
  issue: 10172
  year: 2019
  ident: 2705_CR2
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(18)31665-9
– volume: 5
  issue: 5
  year: 2020
  ident: 2705_CR16
  publication-title: Pain Rep
  doi: 10.1097/PR9.0000000000000843
– volume: 16
  start-page: 494
  year: 1957
  ident: 2705_CR8
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.16.4.494
– volume: 104
  start-page: 293
  issue: 2
  year: 2020
  ident: 2705_CR13
  publication-title: Med Clin North Am
  doi: 10.1016/j.mcna.2019.10.007
SSID ssj0022924
Score 2.6055894
Snippet Hip osteoarthritis is a common disabling condition of the hip joint and is associated with a substantial health burden. We assessed the epidemiological...
Background Hip osteoarthritis is a common disabling condition of the hip joint and is associated with a substantial health burden. We assessed the...
Abstract Background Hip osteoarthritis is a common disabling condition of the hip joint and is associated with a substantial health burden. We assessed the...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 8
SubjectTerms Age
Age-standardized rates
Arthritis
Care and treatment
Collaboration
Diagnosis
Disability evaluation
Disability-adjusted life years
Disease
Females
Global Burden of Disease
Global Health
High income
Hip osteoarthritis
Humans
Incidence
Methods
Middle Aged
Osteoarthritis
Osteoarthritis, Hip - diagnosis
Osteoarthritis, Hip - epidemiology
Pain
Population
Quality-Adjusted Life Years
Risk factors
Sexes
Trends
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9UwFA96B-LL8NvqlAiCD66sbT6a-CKbbgxhQ8TB3kKbpN6Btne7dw_-A_7dnpOkdUXYSx960jbpOTkfSc7vEPK2VUoy5mxunfY5b8smb3ShcgeyhMVyHA9Z_Cen8viMfzkX52nBbZ2OVY46MShqN1hcI99D4HTNFJjbj6vLHKtG4e5qKqFxl2yBClZiQbYODk-_fptCrkrHsrYcYiUwrXxMm1Fybw3au8bs5BL3MQuRy5lpCgj-_-vpG4ZqfojyhlU6ekC2kztJ9yP_H5I7vn9E7p2kDfPH5E_E9N-lWIABne5d2vSOjkuAtA1ZDGs6dHR5saKY8TGAMC0D1BHF3BNagiWhm4GCDdcfKIJy_EL_NBLBfQwEGr9DY1YEvu5z3PmheFDx9xNydnT4_dNxnkov5FZWepNXXNpaQnSjbM29AJ-uVU4Ky1zXwB2BkEBt2blGKaFqD5SuA9bIGuMjuLKnZNEPvX9OqOaWlVUjINTsuGhL7S1virZlwlWu6HRGyvGvG5twybE8xk8T4hMlTeSUAU6ZwCkjM_J-emYVUTlubX2AzJxaIqJ2uDFc_TBpghoPlpwxzgtmS-4r2zad07KB-NN76HaVkXcoCgbnPXTPNil9AQaJCFpmX2JpRPCPyozszFrCfLVz8ihMJumLtfkn3Rl5M5HxSTwD1_vhGtuUUkB0LKAvz6LsTUNiXCOSH_zMeiaVszHPKf3FMqCJw0fBq1Yvbu_WS3K_wsSPcABvhyw2V9f-Fbhjm_Z1mnN_AS4oLoM
  priority: 102
  providerName: ProQuest
Title Global, regional, and national burdens of hip osteoarthritis from 1990 to 2019: estimates from the 2019 Global Burden of Disease Study
URI https://www.ncbi.nlm.nih.gov/pubmed/34980239
https://www.proquest.com/docview/2620938727
https://www.proquest.com/docview/2616599852
https://pubmed.ncbi.nlm.nih.gov/PMC8722328
https://doaj.org/article/e362334403c14e2cbafd96a140ee45b2
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA96gvgifls9lwiCD165bfPRxLc9veMQ7hBxYd9CvsoeaHu4ew_-A_7dziTtskXQF1_60EnbZGaSmWkyvyHkjVNKMhZ86YOOJXeVLa2eqzKALmGxnMBTFv_FpTxf8k8rsdor9YVnwjI8cGbccYQVljHO58xXPNbe2TZoaSEuiJELl1ZfsHljMDWEWjWEFWOKjJLHG1ipG8xErnDPci5KOTFDCa3_zzV5zyhND0zuWaCzB-T-4DrSRe7yQ3Irdo_I3Ythc_wx-ZXx-48oFltAB_uI2i7Q8XcfdSljYUP7lq6vrilmd_Qw_nWCNaKYZ0IrsBp021Ow1_o9RQCO7-iLZiK4iolA83dozoDA133MuzwUDyX-fEKWZ6dfP5yXQ5mF0stab8uaS99IiGSUb3gU4L85FaTwLLQW7giE_3FVG6xSQjURKG0LXo9sMBaCK3tKDrq-i88J1dyzqrYCwsoWhFPp6LmdO8dEqMO81QWpRq4bP2CQYymMbybFIkqaLCkDkjJJUkYW5N3umeuMwPHX1icozF1LRM9ON0CnzKBT5l86VZC3qAoG5zh0z9shVQEGiWhZZiGxDCL4QlVBDictYW76KXlUJjOsDRuDJQA0U8DCgrzekfFJPO_Wxf4G21RSQCQsoC_Psu7thsS4RtQ-YGYz0crJmKeU7mqdkMPho-BBqxf_g0kvyb0aU0HSkbxDcrD9cRNfgYO2dTNyu1k1M3Ln5PTy85dZmplwXdaL38pgNww
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELZKK0EviH8WChgJxIFGTWLHsZEQammrLe2uEGql3tzEdrqVIFm6W6G-AI_DMzJjJ0sjpN56ySHjxHZmPPNN7Jkh5E0ppWDMmshY5SJeJkVUqFhGFmQJi-VY7qP4R2MxPOJfjrPjJfKni4XBY5WdTvSK2jYG_5FvYOJ0xSSY20_TnxFWjcLd1a6ERhCLfXf5C1y22ce9beDv2zTd3Tn8PIzaqgKREamaRykXJhcA3KXJucsArpTSiswwWxVwJ8NsN2VS2ULKTOYOKFUFvYocoT9cGbz3FlkBmKFgFa1s7Yy_flu4eKkKZXQ5-GZgynkXpiPFxgysRY7R0Anum8ZZJHqm0FcM-N8uXDGM_UObV6zg7j1yt4WvdDPI232y5OoH5Pao3aB_SH6HGgLrFAs-IMhfp0VtaffLkZY-amJGm4pOzqYUI0waEN6JT61EMdaFJmC56LyhgBnUB4pJQH4gHg5EgKueQEM_NERh4Ou2w04TxYORl4_I0Y0w5TFZrpvaPSVUccOStMjAta14VibKGV7EZckym9q4UgOSdF9dmzYPOpbj-K69PySFDpzSwCntOaXFgLxfPDMNWUCubb2FzFy0xAze_kZzfqpbhaAdIAfGOI-ZSbhLTVlUVokC_F3nYNjpgLxDUdCoZ2B4pmjDJWCSmLFLbwosxQh4LBmQtV5L0A-mT-6ESbf6aab_raYBeb0g45N45q52zQW2SQTIuMxgLE-C7C2mxLjCzIHwMfOeVPbm3KfUZxOfvRw6BRQvn10_rFfkzvBwdKAP9sb7z8lqikEn_vDfGlmen1-4FwAF5-XLdv1RcnLTS_4vBcJpWg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Global%2C+regional%2C+and+national+burdens+of+hip+osteoarthritis+from+1990+to+2019%3A+estimates+from+the+2019+Global+Burden+of+Disease+Study&rft.jtitle=Arthritis+research+%26+therapy&rft.au=Fu%2C+Ming&rft.au=Zhou%2C+Hongming&rft.au=Li%2C+Yushi&rft.au=Jin%2C+Hai&rft.date=2022-01-03&rft.issn=1478-6362&rft.eissn=1478-6362&rft.volume=24&rft.issue=1&rft.spage=8&rft_id=info:doi/10.1186%2Fs13075-021-02705-6&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-6362&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-6362&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-6362&client=summon